2019
DOI: 10.1177/0391560319834492
|View full text |Cite
|
Sign up to set email alerts
|

The clinical application of combination suprapubic prostatectomy with transurethral resection of the prostate (TURP) in patients with large volume benign prostatic hyperplasia (BPH)

Abstract: Objective: To investigate the safety and efficacy of the combination of suprapubic prostatectomy with transurethral resection of the prostate (TURP) for the treatment of large volume benign prostatic hyperplasia (BPH). Methods: We retrospectively analyzed the clinical data of two methods of treatment with 60 cases of a large volume BPH (>100 g) from January 2011 to 2017; the methods were suprapubic prostatectomy and suprapubic prostatectomy combination with TURP, in which the single open group comprised 30 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…[6,7] Although transurethral resection of the prostate (TURP) is the most common surgical modality for benign prostatic hyperplasia and the reference standard, TURP is limited to prostates <80 mL and associated with a substantial complication rate. [8] Several therapeutic modalities that involve minimally invasive therapies including laser treatment, transurethral microwave thermotherapy, transurethral needle ablation, prostatic stent, intraprostatic injection of botulinum toxin or emergent materials, and prostatic artery embolization (PAE) have been introduced. [9] PAE is a new endovascular technique that can serve as an alternative to more invasive procedures.…”
Section: Introductionmentioning
confidence: 99%
“…[6,7] Although transurethral resection of the prostate (TURP) is the most common surgical modality for benign prostatic hyperplasia and the reference standard, TURP is limited to prostates <80 mL and associated with a substantial complication rate. [8] Several therapeutic modalities that involve minimally invasive therapies including laser treatment, transurethral microwave thermotherapy, transurethral needle ablation, prostatic stent, intraprostatic injection of botulinum toxin or emergent materials, and prostatic artery embolization (PAE) have been introduced. [9] PAE is a new endovascular technique that can serve as an alternative to more invasive procedures.…”
Section: Introductionmentioning
confidence: 99%